Bio Essence (BIOE) Interest Coverage Ratio (2020 - 2026)
Bio Essence (BIOE) recorded quarterly Interest Coverage Ratio of 398.15 in Q1 2026, down 79.12% quarter-over-quarter from 1906.72 in Q4 2025, and up 205.41% on a YoY basis from 130.36 in Q1 2025.
Bio Essence (BIOE) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Bio Essence's Interest Coverage Ratio history runs 7 years deep, the most recent figure standing at 398.15 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 205.41% year-over-year to 398.15; the TTM figure through Mar 2026 stood at 736.7 (up 7358.9% YoY), while the FY2025 annual figure was 411.72, up 4857.64% from the prior year.
- Interest Coverage Ratio was 398.15 for Q1 2026 at Bio Essence, down from 1906.72 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 5101.92 in Q2 2025 to a low of 377.7 in Q1 2025.
- Historically, Interest Coverage Ratio has averaged 351.62 across 5 years, with a median of 30.22 in 2022.
- The sharpest annual moves came in 2024 and 2025: Interest Coverage Ratio sank 538.38% in 2024, then surged 52095539.49% in 2025.
- A 5-year view of Interest Coverage Ratio shows it stood at 127.52 in 2022, then slumped by 381.27% to 358.67 in 2023, then surged by 100.0% to 0.0 in 2024, then soared by 52095539.49% to 1906.72 in 2025, then plunged by 79.12% to 398.15 in 2026.
- The last three Interest Coverage Ratio figures came in at 398.15 (Q1 2026), 1906.72 (Q4 2025), and 20.39 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 13.44 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 108.60 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 5.39 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.31 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 16.72 |
| 10 | Bio Essence | - | - | 319,353.00 | 398.15 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 398.15 |
| Dec 31, 2025 | 1,906.72 |
| Sep 30, 2025 | 20.39 |
| Jun 30, 2025 | 5,101.92 |
| Mar 31, 2025 | -377.70 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | -0.14 |
| Jun 30, 2024 | -3.31 |
| Mar 31, 2024 | -280.13 |
| Dec 31, 2023 | -358.67 |
| Sep 30, 2023 | -150.81 |
| Jun 30, 2023 | -78.47 |
| Mar 31, 2023 | -43.88 |
| Dec 31, 2022 | 127.52 |
| Sep 30, 2022 | -210.00 |
| Jun 30, 2022 | -30.22 |
| Mar 31, 2022 | -43.88 |
| Dec 31, 2021 | -39.24 |
| Sep 30, 2021 | -50.49 |
| Jun 30, 2021 | -9.71 |